v3.26.1
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
May 20, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares authorized 10,000,000,000 10,000,000,000  
Weighted average remaining contract life in years 10 years    
Contractual term 5 years    
Weighted average grant date fair value of options granted $ 3.71    
Weighted-average grant date fair value $ 1.08 $ 1.17  
Stock options intrinsic value exercised $ 0 $ 0  
Stock-based compensation 569,818 $ 105,817  
Unrecognized compensation cost related $ 419,725    
Shares granted 15,898,579    
Total fair value of restricted stock award vested $ 189,058    
Share-Based Payment Arrangement, Option [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Weighted average remaining contract life in years 7 years 8 months 12 days    
Stock options intrinsic value exercised $ 0    
Restricted Stock [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Weighted average remaining contract life in years 3 years    
Weighted average grant date fair value of options granted $ 1.46    
Weighted-average grant date fair value $ 1.08  
Stock-based compensation $ 1,789,105    
Unrecognized compensation cost $ 15,186,700    
Minimum [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares authorized     100,000,000
Expected term 3 years    
Maximum [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares authorized     10,000,000,000
Expected term 12 years    
2022 Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares authorized 150,000    
Percentage of common stock outstanding 4.00%    
Shares remain available for future grants 431,216    
2025 Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares authorized 37,611,971    
Percentage of common stock outstanding 5.00%    
Shares remain available for future grants 21,856,173